125 related articles for article (PubMed ID: 2708546)
1. Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension.
Goldberg MR; Rockhold FW; Thompson WL; DeSante KA
J Clin Pharmacol; 1989 Jan; 29(1):33-40. PubMed ID: 2708546
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparator trials with pinacidil, a potassium channel opener.
Callaghan JT; Goldberg MR; Brunelle R
Drugs; 1988; 36 Suppl 7():77-82. PubMed ID: 3076139
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels.
Goldberg MR
J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S41-7. PubMed ID: 2466178
[TBL] [Abstract][Full Text] [Related]
4. Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension.
Goldberg MR; Rockhold FW; Offen WW; Dornseif BE
Clin Pharmacol Ther; 1989 Aug; 46(2):208-18. PubMed ID: 2758730
[TBL] [Abstract][Full Text] [Related]
5. Vasodilator monotherapy in the treatment of hypertension: comparative efficacy and safety of pinacidil, a potassium channel opener, and prazosin.
Goldberg MR; Sushak CS; Rockhold FW; Thompson WL
Clin Pharmacol Ther; 1988 Jul; 44(1):78-92. PubMed ID: 3292105
[TBL] [Abstract][Full Text] [Related]
6. No deterioration of insulin secretion by the potassium channel opener pinacidil in essential hypertension.
Ligtenberg JJ; Leenaers AD; Van Haeften TW; Smit AJ; Sluiter WJ; Reitsma WD
J Hum Hypertens; 1996 Apr; 10(4):269-76. PubMed ID: 8736460
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
Bareggi SR; Gambaro V; Valenti M; Benvenuti C
Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
[TBL] [Abstract][Full Text] [Related]
8. Pinacidil with and without hydrochlorothiazide. Dose-response relationships from results of a 4 x 3 factorial design study.
Goldberg MR; Offen WW
Drugs; 1988; 36 Suppl 7():83-92. PubMed ID: 3076140
[TBL] [Abstract][Full Text] [Related]
9. Intravenous pinacidil in the acute treatment of hypertension.
Rijk MC; Thien T
J Clin Pharmacol; 1987 Jul; 27(7):468-74. PubMed ID: 3308975
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schirger A; Fisher LD; Shub C; Collins JB; Spiekerman RE
Eur J Clin Pharmacol; 1986; 31(2):133-41. PubMed ID: 3803413
[TBL] [Abstract][Full Text] [Related]
11. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
Friedel HA; Brogden RN
Drugs; 1990 Jun; 39(6):929-67. PubMed ID: 2196168
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
[TBL] [Abstract][Full Text] [Related]
13. Normal insulin release during sustained hyperglycaemia in hypokalaemic periodic paralysis: role of the potassium channel opener pinacidil in impaired muscle strength.
Ligtenberg JJ; Van Haeften TW; Van Der Kolk LE; Smit AJ; Sluiter WJ; Reitsma WD; Links TP
Clin Sci (Lond); 1996 Nov; 91(5):583-9. PubMed ID: 8942397
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers.
Girard P; Saumet JL; Dubois F; Boissel JP
Eur J Clin Pharmacol; 1993; 44(2):177-82. PubMed ID: 8453963
[TBL] [Abstract][Full Text] [Related]
15. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
[TBL] [Abstract][Full Text] [Related]
16. Propranolol antagonizes coronary artery relaxation by a potassium channel opener.
Kalsner S
Life Sci; 1994; 55(14):1109-21. PubMed ID: 7916438
[TBL] [Abstract][Full Text] [Related]
17. Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.
Muiesan G; Fariello R; Muiesan ML; Christensen OE
Eur J Clin Pharmacol; 1985; 28(5):495-9. PubMed ID: 3899669
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
Abraham PA; Halstenson CE; Matzke GR; Keane WF
J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
[TBL] [Abstract][Full Text] [Related]
19. Pinacidil, a new vasodilator, in the treatment of patients with moderate to severe hypertension.
Koliopoulos K; Papadoyannis DE; Karatzas NB
Eur J Clin Pharmacol; 1984; 27(3):287-9. PubMed ID: 6510455
[TBL] [Abstract][Full Text] [Related]
20. Comparative trial of pinacidil versus prazosin in mild to moderate arterial hypertension.
Sterndorff B; Johansen P
Drugs; 1988; 36 Suppl 7():64-6. PubMed ID: 3076137
[No Abstract] [Full Text] [Related]
[Next] [New Search]